RecruitingNCT05762731

Screening for Lung Cancer in Subjects With Family History of Lung Cancer


Sponsor

The University of Hong Kong

Enrollment

1,520 participants

Start Date

Feb 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Lung cancer can be detected via screening of high-risk individuals, i.e current or ex-heavy smokers, with low-dose computer tomography (LDCT) of thorax. The National Lung Screening Trial in US and the NELSON trial in Europe demonstrated reduction in lung cancer mortality with LDCT screening for lung cancer. In Hong Kong, however, there is a prominence of female never-smokers with lung cancer. There is no identifiable risk factors for non-smokers with lung cancer except family history of lung cancer. The hypothesis is that lung cancer screening for subjects with family history of lung cancer, can detect early lung cancer.


Eligibility

Min Age: 50 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Low dose CT thorax and Low dose CT thorax for people with lung cancer. The study is currently recruiting participants at 1 location. People eligible for this study include aged 50 Years to 75 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTLow dose CT thorax

A multi-detector row CT scanner with minimum section collimation of ≤1 mm and minimum number of data acquisition channels ≥ 16will be employed.

DIAGNOSTIC_TESTLow dose CT thorax

Control subjects will also proceed to CT thorax, and outcome measures be compared to subjects


Locations(1)

University of Hong Kong

Hong Kong, Hong Kong, Hong Kong

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05762731


Related Trials